Skip to main contentAll experts

ProfessorJan Radford

(She/her)

Professor in General Practice

Medicine

Orcid identifier0000-0002-5751-0488 (opens in a new tab)⁠
  • Professor in General Practice
    Medicine
  • 0419 885 285 (Mobile)
  • University of Tasmania, Launceston Clinical School, Level 2, Northern Integrated Care Service building, 41 Frankland St,, Launceston, Tasmania, 7250, Australia

RESEARCH SUMMARy

Expertise
Jan is a mixed methods researcher with a particular interest in general practice-based clinical, and medical education research.

Research Themes
Jan’s research aligns with the University’s research theme of Better Health. Her research interests include medical education, the secondary use of routinely collected electronic record data, chronic kidney disease, familial hypercholesterolaemia, Parkinson's disease, and the potential of general practice-based research networks. She leads the Tasmanian arm of PARTNER, the national rural primary care clinical trials network.

Collaboration
Jan has been, and is, involved in major research collaborations. One was an NHMRC partnership grant lead by the University of Notre Dame involving six Australian universities and many other healthcare-related partners. Others are MRFF multimillion-dollar projects involving the University of Tasmania and,or, other universities. These projects investigate various aspects of clinical management including in Australian general practice.

Jan is currently collaborating with academics from most Australian states to set up a general practice-based research network that will, as a major aim, enable rural people to participate in clinical trials.



Jan’s current research includes

-long term follow-up from the EQuIP-GP trial
- optimising the use of antibiotics in general practice in relation to the management of respiratory tract infections-the area of chronic kidney disease (CKD)
-the use of routinely collected general practice electronic health record data to study the epidemiology, quality use of medicines in,
and the monitoring of CKD
-the use of audit and feedback to improve the management of CKD
-collaborating with University of Tasmania academics in projects including anticoagulation use in atrial fibrillation and associated conditions, and the use of medications in people with dementia.

Fields of Research
Primary health care (420319)
Nephrology and urology (320214)
Medicine, nursing and health curriculum and pedagogy (390110)
General practice (420304)
Cardiology (incl. cardiovascular diseases) (320101)
Clinical pharmacology and therapeutics (321402)
Clinical pharmacy and pharmacy practice (321403)
Health services and systems (420399)
Clinical sciences (320299)
Preventative health care (420605)
Exercise physiology (420702)
Educational technology and computing (390405)
Aged care nursing (420502)
Health systems (420311)
Higher education (390303)
Other education (399999)
Educational administration, management and leadership (390403)
Farm management, rural management and agribusiness (300208)
Infectious diseases (320211)
Health and community services (420305)
Health promotion (420603)
Endocrinology (320208)
Clinical chemistry (incl. diagnostics) (320202)
Pain (320218)
Implementation science and evaluation (420312)
Comparative and cross-cultural education (390401)
Teacher education and professional development of educators (390307)
Haematology (320102)
Technical, further and workplace education (390308)
Creative arts, media and communication curriculum and pedagogy (390101)
Aboriginal and Torres Strait Islander public health and wellbeing (450417)
Health surveillance (420310)
Education assessment and evaluation (390402)
Allied health and rehabilitation science (420199)
Paediatrics (321399)
Metabolic medicine (320507)
Aged health care (420301)
Community child health (420601)
Continuing and community education (390301)
Rheumatology and arthritis (320223)
Agricultural economics (380101)
Rehabilitation (420109)
Health economics (380108)
Health management (420309)
Health informatics and information systems (420308)
Health policy (440706)
Epidemiology (420299)
Rural and remote health services (420321)
Medical biochemistry - proteins and peptides (incl. medical proteomics) (320506)
Multimorbidity (420314)
Oncology and carcinogenesis (321199)
Orthodontics and dentofacial orthopaedics (320308)

Research Objectives
Clinical health (200199)
Other health (209999)
Evaluation of health and support services (200299)
Primary care (200310)
Health system performance (incl. effectiveness of programs) (200206)
Assessment, development and evaluation of curriculum (160301)
Evaluation of health outcomes (200202)
Diagnosis of human diseases and conditions (200101)
Health related to ageing (200502)
Learner and learning (160199)
Preventive medicine (200412)
Treatment of human diseases and conditions (200105)
Allied health therapies (excl. mental health services) (200301)
Behaviour and health (200401)
Prevention of human diseases and conditions (200104)
Health education and promotion (200203)
Teaching and instruction technologies (160304)
Other education and training (169999)
Efficacy of medications (200102)
Public health (excl. specific population health) (200499)
Nursing (200307)
Expanding knowledge in the agricultural, food and veterinary sciences (280101)
Neonatal and child health (200506)
Rural and remote area health (200508)
Health inequalities (200204)
Provision of health and support services (200399)
Human pain management (200103)
Teaching and curriculum (160399)
Teacher and instructor development (160303)
Higher education (160102)
Expanding knowledge in education (280109)
Urgent and critical care, and emergency medicine (200311)
Community health care (200302)
Men's health (200504)

Research Appointments
She is also recognised as Associate Fellow of the Australia and New Zealand Association of Healthcare Professional Education.

FUNDED PROJECTS

  • GRANT
    Implementing improved blood pressure measurement in general practice
    1 Sep 2026 - 30 Sep 2030
    People funded by this grant:
    • Sharman J,
    • Schutte A,
    • Nelson M,
    • Gall S,
    • Schlaich M
    Project Total: $1,128,106; High blood pressure (BP) is the single largest modifiable risk factor accounting for the greatest burden of death and disability from cardiovascular disease (CVD) in Australia. Accurate BP measurement is essential so that correct hypertension diagnosis and clinical care can be provided to lower risk for future CVD events (i.e. strokes, heart attacks). Most hypertension is managed in general practice, but it is not feasible for general practitioners (GPs) to perform standardised and accurate BP measurement in this setting, mainly due to time contraints. The result is that GPs do not trust the BP values and this leads to therapeutic inertia and increases in avoidable strokes and heart attacks. This project addresses this problem by implementing an intervention to accurately measure BP by using automated office BP (AOBP) in a process that has been co-designed with GPs, other health care professionals and community. AOBP is a standardised, automated procedure that is undertaken by a trained person in a quiet area outside of the GP examination room prior to consultation. This method is already recommended by guidelines and desired by GPs but not currently used because of barriers faced by GPs, including lack of access to equipment, education and training to measure and interpret AOBP. All these resources will be provided in this project in which AOBP intervention will be implemented in general practice clinics across Australia. It is expected that the AOBP intervention will be associated with significantly increased proportion of patients with treated and controlled hypertension. The project will also determine the essential elements for sustainable adoption of AOBP in general practice according to established implementation science frameworks. Ultimately, the project will provide a high-quality system of care resulting in improved BP measurement, better BP control, lower risk for adverse CVD events, and major health cost savings in Australia. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Partnership Project ($2,256,211); University of Tasmania.
  • GRANT
    Does the improved atrial fibrillation management during hospitalisation persist and improve clinical outcomes?
    1 Aug 2026 - 31 Jan 2028
    People funded by this grant:
    • Gelaw B,
    • Bezabhe W,
    • Dwyer N,
    • Peterson G,
    • Mirkazemi C
    Project Total: $7,000; Atrial fibrillation (AF) affects nearly 500,000 Australians, with prevalence expected to double within two decades due to population ageing, improved survival from AF-associated risk factors, and enhanced detection. AF increases the risk of ischaemic stroke fivefold, and approximately one-third of all strokes are attributable to AF. These events are disproportionately severemore likely to be fatal, recurrent, and economically burdensomecosting the Australian healthcare system an estimated $5 billion annually. Oral anticoagulants (OACs) reduce stroke risk by 64%, yet real-world persistence remains suboptimal. Our recent study at the Royal Hobart Hospital (RHH), published in the European Journal of Clinical Investigation and supported by the 2023 Royal Hobart Research Foundation (RHHRF) Incubator Grant, demonstrated that multidisciplinary care improved guideline-concordant OAC prescribing from 53.8% at admission to 73.8% at discharge. The studys clinical relevance was further underscored in an invited editorial by Boriani et al, a member of the European Society of Cardiology Guidelines Committee. Despite gains in initiation, continuity of OAC therapy post-discharge, incidence of cardiovascular-related rehospitalisation and stroke, and the implementation of integrated AF management remain unexamined in Tasmania and nationally. This study will generate real-world evidence across the following areas: (i) rates and factors of OAC discontinuation at 12 months; (ii) incidence and drivers of cardiovascular-related rehospitalisation and stroke; and (iii) adherence to the ABC pathway (Avoid stroke, Better symptom control, Cardiovascular/comorbidity management) and its impact on clinical outcomes. By addressing these gaps, the study directly supports Australias national health priority of cardiovascular disease by targeting AF and its common comorbidities. These efforts align with national strategies to reduce stroke risk and improve chronic disease management across high-burden populations. Given that OACs are among the most clinically impactful yet high-risk therapies, enhancing their safe and sustained use is a national imperative. Findings will strengthen evidence-based practice, empower multidisciplinary teams, and promote holistic AF care that extends beyond stroke preventionultimately improving patient outcomes in Tasmania and across Australia. Funded by: Royal Hobart Hospital Research Foundation - Research Project Grant ($7,000); University of Tasmania.
  • GRANT
    Improving access to high-value care for osteoarthritis IMPACT-TAS
    30 Jun 2026 - 29 Jun 2031
    People funded by this grant:
    • Aitken D,
    • Sutton L,
    • Radford J,
    • Neil A,
    • Arya D
    Project Total: $4,999,825; This proposal will address a major evidence-practice gap the underuse of first-line, high-value care for osteoarthritis (OA) and the overuse of medications (e.g. opioids) and joint replacement surgery1. The evidence-practice gap is even larger in regional areas such as Tasmania, with the state having some of the longest public wait times in the country for joint replacement surgery2. Tasmania also has the highest rate of opioid prescriptions per capita across all states and territories3. Our proposed translational research program will result in enhanced quality of care, improved patient outcomes, improved efficiency of healthcare delivery, and surgical avoidance/prevention of hospitalisations. Our proposal has been co-developed with end-users from conception, including community, clinicians, consumers, researchers and implementation scientists, health service providers, and policy makers, maximising the potential impact of the project outcomes. For this Stream 2 application, the Chief Investigator A and 73% of all Chief Investigators are resident in MM2-7 areas according to the Modified Monash Model. Summary: People with OA often receive poor quality care that does not align with clinical guidelines. Recommended first-line, core treatments include patient education, exercise and weight loss (where indicated)4-6. Yet, they are rarely used. There is overuse of (potentially harmful) medications and surgery to treat OA1. For example, in Australia, referral rates from GPs to exercise for OA is only 5%, with opioid prescriptions (20%) and referral for surgery (14%) far more common1. These issues have a disproportionate impact on the Tasmanian population, who are on average older, experience greater socioeconomic disadvantage, and experience long elective surgery wait times. Our foundational work with OA patients, GPs and surgeons in Tasmania has highlighted that there are limited options for trusted allied health care to facilitate first-line care. Out-of-pocket cost and accessibility to allied health professionals are major barriers to accessing evidence-based care for OA7 8. Project Impact: This proposal will use a Statewide, coordinated approach to bridge the gap between evidence and practice in OA. Across three major projects, it will use best-practice implementation science methodology to rapidly upscale evidence-based, effective programs for knee and hip OA across Tasmania. Through collaborative efforts with Department of Health, Tasmanian Health Service and Primary Health Tasmania (Tasmanias sole Primary Health Network), it will establish and implement new pathways of referral to evidence-based care, driving systems-level improvements to support high-value, person-centred care. AIM: To improve access and management of knee and hip OA in Tasmania. Project 1 will scale-up an evidence-based exercise and education program (GLA:D) in Tasmania, through public and private partnership. Project 2 will implement and evaluate innovative virtual care models in rural and remote areas of Tasmania. Project 3 will establish, implement and evaluate new pathways of referral to evidence-based care for knee and hip OA, through established partnerships with the States health system. Tasmania is in a u Funded by: Medical Research Future Fund - Grant - Rapid Applied Research Translation ($4,999,843); University of Tasmania ($168,976).
  • CONSULTANCY/CONTRACT RESEARCH
    Single Employer Model (SEM) Program Evaluation
    2 Jun 2026 - 31 Dec 2026
    People funded by this grant:
    • Allen P,
    • Shires L,
    • Radford J
    Project Total: $99,999; Contract to evaluate the Single Employer Model (SEM) delivered by the Tasmanian Health Service. The evaluation will encompass analysis of quantitative program delivery data and a qualitative component consisting of interviews with SEM Registrars, Supervisors, general practice owners, and general practice managers. Funded by: Department of Health (Tasmania) ($99,999); University of Tasmania.
  • GRANT
    Cardio-Diabetic AI-guided Multi-disciplinary disease management program (CD-AIM)
    1 Jun 2026 - 31 May 2031
    People funded by this grant:
    • Marwick T,
    • Whitmore K,
    • Ridge A,
    • Radford J,
    • Wright L
    Project Total: $2,489,786; Could a screening protocol for subclinical LV dysfunction facilitate the selection of patients for a risk-based intervention, and thereby reduce incident HF? The goal of the Cardio-Diabetic AI-Informed disease Management program (CD-AIM) is to reduce the disability and morbidity that would otherwise arise from people with T2DM developing HF, and to preserve functional capacity and quality of life. The objectives are a) to screen asymptomatic individuals with T2DM and without established cardiovascular disease for SBHF with Artificial Intelligence (AI)-guided ECG and echocardiography, b) to undertake a multidisciplinary intervention with cardio-protective strategies, delivered by the study team (Research Nurses and Exercise Physiologists) to delay or prevent their progression to overt HF. Funded by: Medical Research Future Fund - Grant - Preventative and Public Health Research ($2,489,786); University of Tasmania.
  • GRANT
    PERCEIVE-Outreach: A scalable, risk-based model for managing persistent cardiovascular impact in Long Covid
    1 Jun 2026 - 31 May 2030
    People funded by this grant:
    • Huynh Q,
    • Marwick T,
    • Howden E,
    • Radford J,
    • Carrington M
    Project Total: $2,999,687; Despite starting as a respiratory infection by SARS-CoV-2, cardiac injury is commonly reported in COVID-19. Myocardial damage (inflammation and fibrosis), shortness of breath, and chronic fatigue are reported in most recovered patients after 2-3 months, and ongoing cardiac disability is likely a complication in Post-Acute Sequelae of COVID-19 (PASC, commonly known as Long COVID). This research aims to determine key factors that impact hospital admission and death in PASC. These findings will be used to develop a novel screening tool to identify those patients with a high risk of adverse outcomes and a world-first risk-guided healthcare program to effectively manage these risks in people with PASC. This research will include two study samples: A linked dataset provided by Department of Health includes all 7.5 million patients who tested either positive or negative with COVID-19 in Victoria during 2019-22. We will define PASC as monthly occurrence of direct healthcare costs for at least two out of three months after the initial COVID-19 infection to identify people with more severe PASC. This large dataset offers an opportunity to comprehensively investigate the burden of COVID-19. This will be complemented by our ongoing prospective cohort of 979 older Australians recruited from community, with 8-year follow-up (2015-23). This is the world-first paired data BEFORE and AFTER COVID-19 infection with excellent levels of data granularity to enable examination of most key factors of PASC prognosis. The development of a novel risk-guided healthcare program for PASC from our project will result in a reduction in adverse events, hospital admissions, costs, and improved quality of life. This will directly benefit not only millions of patients, but also our health system and clinicians and healthcare providers. It will maximise any investment return in the intervention, an outcome that will be particularly appreciated by healthcare providers with resource constraints. Funded by: Medical Research Future Fund - Grant - Emerging Priorities and Consumer Driven ($2,999,687); University of Tasmania.
  • GRANT
    Implementing ParkinsonNet to improve equitable access to high quality care for people with Parkinson's Disease in rural and remote Australia
    1 Sep 2025 - 31 Aug 2030
    People funded by this grant:
    • Callisaya M,
    • McGinley J,
    • Klaic M,
    • Russell T,
    • Bloem B
    Project Total: $2,883,922; Parkinsons Disease (PD) is a progressive neurological condition with no cure. PD causes major disability and significantly increase the risk of falls, hospitalisation and need for care. There is strong evidence that therapies delivered by expert allied health professionals according to guidelines can reduce adverse outcomes, extend active life years and delay transition to residential care. The challenge is that in Australia there are no guidelines for PD care, and people with PD report difficulty finding and accessing expert care, especially those living in rural and remote areas. ParkinsonNet is an innovative evidence-based and cost-effective model originating from the Netherlands that improves access to high-quality networked care and improved health outcomes (e.g., reduced disability, rates of hospitalisation, lower healthcare costs). It supports health professionals deliver, quality care through training, mentoring, visible networks, audits and continuous improvement. It has been successfully implemented in the USA and Europe, and is recognised internationally as a gold standard model. However, challenges to implementation in the Australian rural and remote context exist, and include travel distance and a lack of a specialist health workforce. The aims of our study are to: 1) identify the barriers, facilitators and required adaptions to ParkinsonNet for successful implementation in rural/remote Australia; 2) evaluate reach, adoption, acceptability, sustainability and potential for scale-up and 3) determine changes to: a) health professional knowledge, self-efficacy and evidence-based practice; and b) health outcomes and experiences for people with PD. The outcomes of the project will be improved access to high-quality care through the ParkinsonNet model which has proven health outcomes; improved workforce capability and capacity, and reduced healthcare costs. The output will be a national centre and implementation roadmap ready for scale-up across the country. Funded by: Medical Research Future Fund - Grant - Dementia, Ageing and Aged Care Mission ($2,873,778); University of Tasmania.
  • GRANT
    Addressing the health needs of Tasmania: The Tasmanian Collaboration for Health Improvement (TCHI)
    1 May 2025 - 30 Apr 2027
    People funded by this grant:
    • Aitken D,
    • Arya D,
    • Powell S,
    • Sharman J,
    • Winzenberg T
    Project Total: $1,000,000; Tasmania has the oldest, most rapidly ageing population in Australia and some of the poorest health outcomes of any Australian state or territory due to higher levels of socioeconomic disadvantage, chronic disease and disability. It faces regional health challenges with a highly geographically dispersed population. To address these health needs, the Tasmanian Collaboration for Health Improvement (TCHI) was formally established in 2018. TCHI is a collaborative partnership between the Tasmanian Department of Health and Tasmanian Health Services, the University of Tasmania, Primary Health Tasmania (Tasmanias sole Primary Health Network) and Health Consumers Tasmania. This is a strong, committed partnership evidenced by the major investment from its partners since its inception. It has an established governance and leadership structure. With one health system, one Primary Health Network and one University working together, the collaboration is in a unique position to rapidly and effectively translate research evidence into practice and policy and improve the health outcomes for Tasmanians. TCHI has co-developed a series of five priority projects that will address specific health needs in Tasmania. Project 1 will implement and evaluate a co-designed intervention in general practice to reduce unwarranted surgical referral for osteoarthritis. Project 2 will implement a nation-leading model for monitoring and managing blood pressure in primary care to reduce the burden of hypertension in the State. Project 3 focuses on improving services, health outcomes and preventing hospitalisations for individuals that are frequently admitted to hospital. Project 4 aims to reduce the pressure on emergency departments through the implementation of a novel Emergency Department Learning Health System that has been co-developed with all TCHI partners. Project 5 will co-design approaches for measuring and monitoring racism experienced by First Peoples in Tasmanias public health system. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Collaborations in Health Services Research ($2,000,000); University of Tasmania.
  • GRANT
    Development of a co-designed, multifaceted intervention in general practice to improve the quality of knee and hip osteoarthritis care in Tasmania
    1 Feb 2025 - 31 Dec 2025
    People funded by this grant:
    • Sutton L,
    • Aitken D,
    • Mulford J,
    • Shearer L,
    • Radford J
    Project Total: $20,000; A pilot prototype of an intervention to address osteoarthritis mismanagement in Southern Tasmania will be co-designed and trialled with GP practices. This pilot study will provide critical feasibility information to inform a larger-scale effectiveness trial that is scalable Statewide and nationally to address Australias elective surgery crisis, reducing inappropriate referral for joint replacement surgery and improving patient outcomes. Funded by: Donation via Menzies Institute for Medical Research - Donation ($20,000); University of Tasmania.
  • GRANT
    National Multidisciplinary Primary Care Research, Policy and Advocacy Consortium
    1 Jan 2025 - 28 Feb 2029
    People funded by this grant:
    • Kidd M,
    • Radford J
    Project Total: $0; Members of the National Multidisciplinary Primary Care Research, Policy and Advocacy Consortium (The Consortium) will work collaboratively to support future-focused ways of thinking about primary care delivered through multidisciplinary team (MDT)-based care. The Consortium will generate, coordinate, and disseminate knowledge on innovative models of MDT-based primary care that improve health outcomes for people living in all parts of Australia. The Consortium brings together consumers and expert partners from across the country to identify where, when, and how MDT-based primary care can meaningfully address challenges facing our health care system. The Consortium will be a major national resource that supports ongoing federal, state and territory programs of primary care reform, strengthens the evidence base on primary care service delivery and outcomes, and accelerates the translation of knowledge into improvements in clinical care, while also increasing nationwide primary care clinician researcher capacity. Funded by: Medical Research Future Fund - MRFF 2023 Integrated Multidisciplinary Models of Primary Care Grant; University of Tasmania.
  • GRANT
    Optimising Oral Anticoagulant Use in Hospitlised Patients with Atrial Fibrillation: An Opportunity Enhancement Intervention.
    1 Jan 2025 - 30 Dec 2026
    People funded by this grant:
    • Bezabhe W,
    • Peterson G,
    • Dwyer N,
    • Mirkazemi C,
    • Black DA
    Project Total: $25,000; Appropriate use of oral anticoagulants (OACs) reduces the risk of stroke and death by 64% and 25%, respectively. In our previous study that compared OAC prescribing at admission (community) and discharge (hospital), we confirmed that, in routine care, the RHH team improved the guideline appropriateness of OAC use in patients with atrial fibrillation. However, half of the patients with guideline-inappropriate OAC prescribing at admission were discharged without correction. The efficiency of correcting inappropriate OAC use varied significantly across RHH admission wards. An intervention that enhances the likelihood of the RHH care team to correct inappropriate OAC use is required. Funded by: Royal Hobart Hospital Research Foundation - Grant-Project ($25,000); University of Tasmania.
  • GRANT
    Priority-setting for the co-design of services for people with high healthcare service utilisation
    1 Jan 2025 - 31 Dec 2026
    People funded by this grant:
    • Radford J,
    • Winzenberg T,
    • Morley C,
    • Tran V,
    • Unwin M
    Project Total: $113,575; A small proportion of people impose a disproportionately high burden on the healthcare system, called high healthcare service utilisation (HSU). These people have complex care needs, often having multiple chronic conditions. Interventions aimed at improving outcomes for people with HSU have had limited effectiveness. A major reason for this is a lack of understanding of how people with different forms of HSU differ in their characteristics and potential needs. For example, people who frequently use hospital emergency departments (EDs) are likely to have different health and/or social problems than those who require frequent hospital admissions and so require different care delivered in different ways. This project aims to understand the issues driving HSU across Tasmania and develop an agreed rank of priorities for addressing issues related to HSU in Tasmania. We will undertake semi-structured interviews with a purposive sample of key stakeholders (i.e., acute and primary care clinicians, policy makers, and NGO representatives). We will combine the results of this study with the results of our study that used stories of Tasmanians with lived experience of HSU. Results of the two studies will inform a priority setting workshop. At project end we aim to have an agreed priority area to which we will apply co-design methodology to (re)design a service to address this priority area. Funded by: Royal Australian College of General Practitioners - Grant - RACGP/HCF Research Grant ($113,575); University of Tasmania ($319).
  • GRANT
    Use of Cardiovascular Disease Preventive Medications in Tasmanian Cancer Survivors
    1 Jan 2025 - 31 Dec 2025
    People funded by this grant:
    • Bezabhe W,
    • Peterson G,
    • Black DA,
    • Mirkazemi C,
    • Dwyer N
    Project Total: $10,000; The number of Tasmanians living with cancer is estimated to be over 30,000 and is increasing. A study using the Tasmanian Cancer Registry data found that heart and blood vessel disorders known as cardiovascular disease (CVD) are the leading causes of non-cancer death in Tasmanians with cancer. Over a quarter of all deaths and more than half of all non-cancer deaths are caused by CVD. However, no study examined the use of CVD preventive medications in Tasmanian cancer survivors. This study aims to investigate CVD preventive medication use following acute coronary syndrome admission in Tasmanian cancer survivors. Funded by: Royal Hobart Hospital Research Foundation - Grant-Incubator ($10,000); University of Tasmania.
  • GRANT
    The QUOLL-CKD study: QUality use Of pathoLogy for people Living with Chronic Kidney Disease.
    31 May 2024 - 31 Dec 2026
    People funded by this grant:
    • Jose M,
    • Radford J,
    • Prentice L,
    • Jose K,
    • Hensher M
    Project Total: $279,792; There are over 2 million Australians with chronic kidney disease, with an annual cost estimate of nearly $10 billion. Clinical guidelines recommend pathology testing up to 12 times each year, yet there is virtually no scientific evidence supporting this. Our group has previously reported complete testing occurs around 30% of the time, but we really dont know what the frequency of testing is that will lead to optimal outcomes for people with kidney disease. This project will adopt a whole-of-state approach, using a pathology dataset that includes nearly 90% of the population living in regional, rural and remote areas of Australia over a 20 year follow-up period. Together with medical students and trainee doctors, we will examine the actual frequency of testing, provide optimal models of testing that will lead to better outcomes, test these models with consumers and health professionals and provide an economic and environmental assessment of these models to achieve quality use of pathology testing for Australians with chronic kidney disease. Funded by: Department of Health and Aged Care - Quality Use of Pathology Project Grants ($279,792); University of Tasmania.
  • GRANT
    Geriatric Antipsychotic Stewardship (GApS) Program for Behavioural and Psychological Symptoms of Dementia and Delirium: a pilot study
    1 Jan 2024 - 30 Nov 2027
    People funded by this grant:
    • Hoyle D,
    • Peterson G,
    • Fasnacht M,
    • Adamczewski B,
    • Salahudeen M
    Project Total: $9,999; The high prevalence of antipsychotic use in aged care has led to concern of inappropriate sedation. Emerging evidence suggests that hospitalisation is contributing to this issue. This study will trial a geriatric antipsychotic stewardship program for non-psychiatric admissions of older people to improve the use and review of antipsychotics during and after hospitalisation. Funded by: Royal Hobart Hospital Research Foundation - Grant-Incubator ($9,999); University of Tasmania ($9,529).
  • GRANT
    Giving people with Parkinson's Disease a voice
    1 Jan 2024 - 31 Dec 2024
    People funded by this grant:
    • Callisaya M,
    • Alty J,
    • St George R,
    • Radford J,
    • Giles L
    Project Total: $26,583; Parkinsons Disease (PD) is the fastest growing neurological condition in the world and second most common after dementia. It is a debilitating condition with no cure. Research is crucial for developing new therapies to reduce symptoms and improve care. However, there is no simple way for people with PD to volunteer for studies or have a voice in setting research priorities. Delays in finding participants severely hinders researchers too resulting in studies taking longer to deliver, heightened costs and diminished effectiveness. A register of research-interested people with PD and an annual survey highlighting gaps in care and patient outcomes would help to solve this problem. The aim of this study is to design and implement a PD research-register and annual survey of healthcare experiences and unmet needs, with people with PD and their care partners. Funded by: Donation via Menzies Institute for Medical Research - Donation ($26,583); University of Tasmania.
  • GRANT
    Optimal Implementation of Antimicrobial Stewardship in General Practice: OPTIMAS-GP study
    1 Jan 2024 - 31 Dec 2028
    People funded by this grant:
    • Bonney A,
    • Metusela C,
    • Keighley C,
    • Barnett S,
    • Eckermann S
    Project Total: $2,767,445; The OPTIMAS-GP study is a program of implementation science research in 3 stages designed to determine the best strategies for reducing inappropriate antibiotic use in Australian general practice. The study will target community acquired respiratory infections. Funded by: Medical Research Future Fund - Grant-Clinical Trial Activity Initiative; Monash University; University of Wollongong; Bond University; University of Tasmania.
  • GRANT
    Putting people first: using stories of lived experience to improve health care for Tasmanians who frequently use healthcare services.
    1 Jan 2024 - 30 Nov 2025
    People funded by this grant:
    • Winzenberg T,
    • Radford J,
    • Tran V,
    • Morley C
    Project Total: $61,911; A small proportion of people impose a disproportionately high burden on the healthcare system, called high healthcare service utilisation (HSU). These people have complex care needs, often having multiple chronic conditions. Interventions aimed at improving outcomes for people with HSU have had limited effectiveness. A major reason for this is a lack of understanding of how people with different forms of HSU differ in their characteristics and potential needs. For example, people who frequently use hospital emergency departments (EDs) are likely to have different health and/or social problems than those who require frequent hospital admissions and so require different care delivered in different ways. This project aims to understand the issues driving HSU across Tasmania. We will undertake semi-structured interviews with a purposive sample of Tasmanias with lived experience of HSU across the three regions (north, north-west, and south) to identify the issues specific to each region and / or type of HSU. Funded by: The MPST Foundation Ltd - Grant ($61,911); University of Tasmania.
  • GRANT
    Increasing the rural and regional General Practitioner workforce through integrated pathways. A statewide approach.
    3 Dec 2023 - 31 May 2025
    People funded by this grant:
    • Prior S,
    • Shires L,
    • Coe S,
    • Dallas A,
    • Williams B
    Project Total: $149,982; The aim of this project is to explore barriers and enablers to the recruitment and retention of General Practitioners (GPs) in Tasmania by evaluating the current training pathway. The pathway consists of programs and initiatives from discrete organisations along the training continuum. Understanding how these elements connect and support medical learners is vital to the design of a cohesive pathway. Funded by: Royal Australian College of General Practitioners - Grant-Education Research Grant ($149,982); University of Tasmania.
  • GRANT
    Hospitalisation as an opportunity to optimise anticoagulant treatment in patients with atrial fibrillation
    1 Jan 2023 - 30 Jun 2024
    People funded by this grant:
    • Bezabhe W,
    • Peterson G,
    • Radford J,
    • Boland C,
    • Salahudeen M
    Project Total: $9,985; Our recent studies indicate that many community-based patients with atrial fibrillation and a high stroke risk still do not receive the recommended anticoagulant therapy. This study will examine anticoagulant use in patients with atrial fibrillation upon admission and discharge and determine whether hospitalisation represents an opportunity to improve the quality of care. Funded by: Royal Hobart Hospital Research Foundation - Grant-Incubator ($9,985); University of Tasmania.
  • GRANT
    The PARTNER network
    1 Sep 2022 - 31 Dec 2026
    People funded by this grant:
    • Emery J,
    • Kirke A,
    • Stocks N,
    • Gonzalez-Chica D,
    • Radford J
    Project Total: $3,717,785; The PARTNER network aims to connect rural & regional Australians to new clinical trials & research. It will be a national general practice-based research network (PBRN) that connects Australians to potential trials through their local general practice. Funded by: Medical Research Future Fund - Grant - NCII Rural Regional Remote Clinical Trial; University of Melbourne; University of Adelaide; University of Queensland; University of Western Australia; University of Tasmania.
  • GRANT
    IMplementing clinical Pathways for Acute Care in Tasmania (IMPACT)
    1 Apr 2022 - 31 Mar 2028
    People funded by this grant:
    • Tran V,
    • Prior S,
    • Neil A,
    • Sharman J,
    • Radford J
    Project Total: $2,919,109; Clinical pathways (CPs) are multidisciplinary tools enabling large-scale consistent practice of evidence-based medicine, and have the potential to improve patient care and reduce pressure on Emergency Departments. The effectiveness of CPs in Australia is not well known. IMPACT will utilise a consumer-driven approach to investigate barriers for CP use, develop a scalable and sustainable implementation strategy for CPs, and identify CP priorities to drive further excellence in health care. Funded by: Medical Research Future Fund - Grant-2022 Models of Care to Improve the Efficienc ($2,919,109); University of Tasmania ($108,157).
  • GRANT
    A comprehensive examination of potentially modifiable vascular disease risk factors and their consequences in Tasmania.
    1 Jan 2020 - 31 Dec 2020
    People funded by this grant:
    • Jose M,
    • Burgess J,
    • Prentice L,
    • Cuthbertson L,
    • Cash E
    Project Total: $24,868; Vascular disease devastates the lives of many Tasmanians. Using a statewide, data-linkage approach, we will report the age, gender and geographic distribution of risk factors for vascular disease (including diabetes, high cholesterol, vitamin D deficiency and kidney disease), then see how these risk factors link to illness and death. Funded by: Royal Hobart Hospital Research Foundation - Grant-Project ($24,868); University of Tasmania.
  • CONSULTANCY/CONTRACT RESEARCH
    Senior Research Fellow
    1 Jan 2020 - 31 Dec 2025
    People funded by this grant:
    • Radford J,
    • Ogden K,
    • Church R
    Project Total: $549,999; Funding for a Level C position at 0.4 FTE for 3 years. New agreement with CCF for 2023-2025 for level C position 0.8FTE for 3 years. Funded by: Clifford Craig Foundation ($549,999); University of Tasmania.
  • GRANT
    Factors associated with bowel cancer survival in Tasmania: A data linkage study
    31 Jul 2018 - 31 Jul 2019
    People funded by this grant:
    • Lee S,
    • Radford J,
    • Versace V,
    • Obamiro K
    Project Total: $9,868; Funded by: University of Tasmania - Grant - DKD Research Theme; University of Tasmania ($9,868).